AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, C. S.
Right arrow Articles by Yeung, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, C. S.
Right arrow Articles by Yeung, H. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

False-Positive Findings on 18F-FDG PET/CT: Differentiation of Hibernoma and Malignant Fatty Tumor on the Basis of Fluctuating Standardized Uptake Values

Clare S. Smith1, Julia Teruya-Feldstein2, James F. Caravelli1 and Henry W. Yeung1

1 Department of Radiology and Nuclear Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.


Figure 1
View larger version (105K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 82-year-old woman with newly diagnosed lymphoma. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from staging 18F-FDG PET/CT show hypermetabolic enlarged spleen and right retroperitoneal adenopathy (white arrows, B–D) and small focus of increased activity in left paraspinal region (black arrow).

 

Figure 2
View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 82-year-old woman with newly diagnosed lymphoma. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from staging 18F-FDG PET/CT show hypermetabolic enlarged spleen and right retroperitoneal adenopathy (white arrows, B–D) and small focus of increased activity in left paraspinal region (black arrow).

 

Figure 3
View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C 82-year-old woman with newly diagnosed lymphoma. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from staging 18F-FDG PET/CT show hypermetabolic enlarged spleen and right retroperitoneal adenopathy (white arrows, B–D) and small focus of increased activity in left paraspinal region (black arrow).

 

Figure 4
View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D 82-year-old woman with newly diagnosed lymphoma. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from staging 18F-FDG PET/CT show hypermetabolic enlarged spleen and right retroperitoneal adenopathy (white arrows, B–D) and small focus of increased activity in left paraspinal region (black arrow).

 

Figure 5
View larger version (80K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1E 82-year-old woman with newly diagnosed lymphoma. Coronal (E) and axial (F) PET, axial CT (G), and fusion axial PET/CT (H) images from FDG PET/CT performed after four cycles of rituximab, vincristine, doxorubicin, cyclophosphamide, and prednisone (R-CHOP) therapy show resolution of activity in spleen and retroperitoneum and increase in activity in left paraspinal region (arrow). Biopsy result was hibernoma.

 

Figure 6
View larger version (89K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1F 82-year-old woman with newly diagnosed lymphoma. Coronal (E) and axial (F) PET, axial CT (G), and fusion axial PET/CT (H) images from FDG PET/CT performed after four cycles of rituximab, vincristine, doxorubicin, cyclophosphamide, and prednisone (R-CHOP) therapy show resolution of activity in spleen and retroperitoneum and increase in activity in left paraspinal region (arrow). Biopsy result was hibernoma.

 

Figure 7
View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1G 82-year-old woman with newly diagnosed lymphoma. Coronal (E) and axial (F) PET, axial CT (G), and fusion axial PET/CT (H) images from FDG PET/CT performed after four cycles of rituximab, vincristine, doxorubicin, cyclophosphamide, and prednisone (R-CHOP) therapy show resolution of activity in spleen and retroperitoneum and increase in activity in left paraspinal region (arrow). Biopsy result was hibernoma.

 

Figure 8
View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1H 82-year-old woman with newly diagnosed lymphoma. Coronal (E) and axial (F) PET, axial CT (G), and fusion axial PET/CT (H) images from FDG PET/CT performed after four cycles of rituximab, vincristine, doxorubicin, cyclophosphamide, and prednisone (R-CHOP) therapy show resolution of activity in spleen and retroperitoneum and increase in activity in left paraspinal region (arrow). Biopsy result was hibernoma.

 

Figure 9
View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1I 82-year-old woman with newly diagnosed lymphoma. Photomicrograph of biopsy specimen from left paraspinal mass shows benign adipose cells of brown fat type. Cells have distinct cell borders with multiple vacuoles in cytoplasm or eosinophilic granular cytoplasm with areas composed of mature adipose tissue. (H and E, x40)

 

Figure 10
View larger version (90K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A 54-year-old man with increasing level of prostate-specific antigen after radical prostatectomy. Coronal PET images from serial 18F-FDG PET/CT show focus of increased activity in fatty-appearing lesion adjacent to left teres major muscle (arrow, B and C). Standard uptake value fluctuates over time from no uptake (A) through 6.7 approximately 1 month later (B) to 5.0 3 months after that (C).

 

Figure 11
View larger version (84K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B 54-year-old man with increasing level of prostate-specific antigen after radical prostatectomy. Coronal PET images from serial 18F-FDG PET/CT show focus of increased activity in fatty-appearing lesion adjacent to left teres major muscle (arrow, B and C). Standard uptake value fluctuates over time from no uptake (A) through 6.7 approximately 1 month later (B) to 5.0 3 months after that (C).

 

Figure 12
View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C 54-year-old man with increasing level of prostate-specific antigen after radical prostatectomy. Coronal PET images from serial 18F-FDG PET/CT show focus of increased activity in fatty-appearing lesion adjacent to left teres major muscle (arrow, B and C). Standard uptake value fluctuates over time from no uptake (A) through 6.7 approximately 1 month later (B) to 5.0 3 months after that (C).

 

Figure 13
View larger version (62K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D 54-year-old man with increasing level of prostate-specific antigen after radical prostatectomy. Axial contrast-enhanced CT scan obtained 20 months after A–C shows stability in both size and appearance of fatty lesion adjacent to left teres major muscle (arrow).

 

Figure 14
View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A 55-year-old man with newly diagnosed colorectal cancer. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from 18F-FDG PET/CT show increased FDG activity within numerous hepatic metastatic lesions (white arrow). Focus of increased activity deep in relation to left latissimus dorsi muscle within fatty-appearing lesion (black arrow) suggests hibernoma.

 

Figure 15
View larger version (76K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B 55-year-old man with newly diagnosed colorectal cancer. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from 18F-FDG PET/CT show increased FDG activity within numerous hepatic metastatic lesions (white arrow). Focus of increased activity deep in relation to left latissimus dorsi muscle within fatty-appearing lesion (black arrow) suggests hibernoma.

 

Figure 16
View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C 55-year-old man with newly diagnosed colorectal cancer. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from 18F-FDG PET/CT show increased FDG activity within numerous hepatic metastatic lesions (white arrow). Focus of increased activity deep in relation to left latissimus dorsi muscle within fatty-appearing lesion (black arrow) suggests hibernoma.

 

Figure 17
View larger version (105K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3D 55-year-old man with newly diagnosed colorectal cancer. Coronal (A) and axial (B) PET, axial CT (C), and fusion axial PET/CT (D) images from 18F-FDG PET/CT show increased FDG activity within numerous hepatic metastatic lesions (white arrow). Focus of increased activity deep in relation to left latissimus dorsi muscle within fatty-appearing lesion (black arrow) suggests hibernoma.

 

Figure 18
View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3E 55-year-old man with newly diagnosed colorectal cancer. Axial contrast-enhanced CT scan obtained 12 months after chemotherapy shows decrease in size of hepatic metastatic lesions and decrease in size of fatty lesion deep in relation to left latissimus dorsi muscle.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.